AWM Investment Company Inc. Sells 293,536 Shares of Orthofix Medical Inc. $OFIX

Key Points

• AWM Investment Company Inc. significantly reduced its stake in Orthofix Medical, selling 293,536 shares and now holding only 66,611 shares, which represents an 81.5% decrease in ownership.
• Juniper Investment Company LLC increased its stake in Orthofix Medical by 123.5%, acquiring over 1 million additional shares, highlighting a shift in investor sentiment.
• Orthofix Medical missed analysts' earnings expectations for the latest quarter, reporting a loss of ($0.36) earnings per share, while revenue was slightly above estimates at $203.12 million.

AWM Investment Company Inc. cut its holdings in Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 81.5% in the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 66,611 shares of the medical device company's stock after selling 293,536 shares during the quarter. AWM Investment Company Inc. owned about 0.17% of Orthofix Medical worth $1,086,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in OFIX. Lazard Asset Management LLC acquired a new stake in Orthofix Medical during the fourth quarter worth about $45,000. US Bancorp DE raised its position in Orthofix Medical by 684.6% in the first quarter. US Bancorp DE now owns 5,673 shares of the medical device company's stock valued at $93,000 after purchasing an additional 4,950 shares during the period. Tower Research Capital LLC TRC grew its stake in shares of Orthofix Medical by 120.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 8,458 shares of the medical device company's stock valued at $148,000 after buying an additional 4,627 shares in the last quarter. State of Wyoming grew its stake in shares of Orthofix Medical by 206.8% in the fourth quarter. State of Wyoming now owns 9,432 shares of the medical device company's stock valued at $165,000 after buying an additional 6,358 shares in the last quarter. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management acquired a new stake in shares of Orthofix Medical in the first quarter valued at $164,000. 89.76% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Orthofix Medical

In related news, insider Aviva Mcpherron sold 3,728 shares of the firm's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $10.51, for a total transaction of $39,181.28. Following the sale, the insider directly owned 46,322 shares in the company, valued at $486,844.22. This trade represents a 7.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.30% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. JMP Securities reaffirmed a "market perform" rating on shares of Orthofix Medical in a research report on Friday, June 6th. Barrington Research raised Orthofix Medical to a "strong-buy" rating and set a $16.00 price objective for the company in a research note on Monday, June 23rd. Finally, Wall Street Zen upgraded Orthofix Medical from a "sell" rating to a "hold" rating in a report on Saturday, August 9th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $21.50.

Orthofix Medical Stock Down 1.0%

Shares of NASDAQ OFIX traded down $0.15 during mid-day trading on Friday, reaching $14.55. The company had a trading volume of 263,659 shares, compared to its average volume of 475,984. The stock has a market capitalization of $574.64 million, a PE ratio of -4.59 and a beta of 0.86. Orthofix Medical Inc. has a twelve month low of $10.24 and a twelve month high of $20.73. The stock's 50 day moving average is $12.54 and its 200-day moving average is $13.34. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.50 and a current ratio of 2.67.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The medical device company reported ($0.36) EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.40). The company had revenue of $203.12 million for the quarter, compared to analyst estimates of $196.89 million. Orthofix Medical had a negative net margin of 15.29% and a negative return on equity of 25.43%. Orthofix Medical has set its FY 2025 guidance at EPS. As a group, equities analysts anticipate that Orthofix Medical Inc. will post -2.81 earnings per share for the current fiscal year.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.